Global Veterinary Anti-Infectives Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Combining innovation and animal health, the Global Veterinary Anti-infectives Market pioneers novel solutions to combat emerging infections

The Global Veterinary Anti-infectives Market is estimated to be USD 3.51 Bn in 2023 and is expected to reach USD 5.76 Bn by 2028 growing at a CAGR of 10.38%.

There is a rising need for preventative measures in the animal healthcare sector due to increased zoonotic and foodborne diseases. There is a rising demand for anti-infective drugs such as vaccinations, antibiotics, and antifungal medications to prevent and manage these diseases. Governments all over the world are putting laws into place to stop the spread of zoonotic and foodborne illnesses. The use of anti-infective animal products is mandated by these rules, increasing the demand for veterinary anti-infective products. Furthermore, with the increasing trend of pet ownership, the demand for veterinary anti-infective products has also increased. Pet owners are becoming more conscious about the health and well-being of their pets and are willing to invest in preventive and curative healthcare measures.

However, the use of counterfeit medicines in the veterinary anti-infective market can restrain the market's growth because these medicines may not contain the appropriate active ingredients, resulting in reduced efficacy, leading to treatment failure, prolonged illness or even death in animals. Also, it can cause health risks as it may contain harmful ingredients. Counterfeit medicines are often sold at lower prices than genuine products, which can pressure legitimate manufacturers and distributors to lower their prices to remain competitive. This can lead to lower profit margins and reduced investment in research and development, which can slow the introduction of new products and limit market growth.

The market for veterinary antibiotics is exhibiting a growing trend of increased corporate cooperation. Collaboration offers businesses the chance to integrate technology and work with various more diversified products. It also enhances the antibiotics' quality and production efficiency. As a result, businesses in the veterinary antibiotics market are emphasizing partnerships. For instance, in September 2022, Veterinary Innovative Partners and GlobalVetLink, a US-based provider of software services and informatics solutions in the field of animals, installed GlobalVetLink Compliance Assistant, a comprehensive SaaS platform designed to make animal health simple.

New veterinary anti-infectives require a large expenditure in research and development, which involves testing the product's efficacy and safety on animals. Consumers usually suffer for these expenses through higher prices. Also, compared to the market for human medications, the market for veterinary anti-infectives is rather small, which means that the expenditures associated with developing and producing these drugs are dispersed over fewer sales. To compensate for the reduced market, this may lead to higher prices. Hence, the high cost associated with veterinary anti - infective market is hampering the market's growth.

Market Segmentations

• The Global Veterinary Anti-Infectives Market is segmented based on Animal Type, Drug Class, Route of Administration, End User, and Geography.
• By Animal Type, the market is classified into Livestock and Companion.
• Livestock Animal Type segment has the largest market share. The growth of this segment is highly attributable to the high population of cattle across the world and the dominance of cattle farming as a major source of income for various people in many countries.
• By Drug Class, the market is classified into Antimicrobial Agents, Antifungal Agents, Antiviral Agents, and Antiparasitic Agents.
• Antimicrobial Agents have the highest market share among the drug class. Major antimicrobial agents such as Penicillins, Cephalosporins, and Tetracyclines account for a higher growth rate.
• By Route of Administration, the market is classified into Oral, Parenteral, and Topical.
• The Oral Route of Administration has the highest market share as it is easy to use method. Also, using the oral method of administration helps to extend the time that the medication takes to take effect because it reduces the number of visits to the vet and hospital.
• By End User, the market is classified into Veterinary Clinics, Retail Pharmacies, and E-commerce.
• Retail Pharmacies hold the largest market share due to the accessibility of medications and immunizations through retail pharmacies. In addition, it is projected that digitizing retail pharmacies will help to lower the possibility of prescription error and drive category growth.
• By Geography, the market is classified into the Americas, Europe, Middle East & Africa and Asia-Pacific.
• The Americas has the largest market share as the region is rapidly growing due to the presence of advanced animal healthcare programs. Furthermore, the rising disease burden pushes the need for effective treatment options which is expected to project market growth.

Recent Development

• MEXICO Santgar, a leading veterinary pharmaceutical company in Mexico, Santgar Announces the Launch of Its Newest Medicine, 'Excentera LS,'which will treat Immune-Mediated Disorders that cause dry eyes in dogs - February 2023.
• Increxxa, a recently approved drug for livestock respiratory disease, was introduced by Elanco Animal Health Company, a pharmaceutical business with US headquarters that produces medications and immunizations for pets and animals. Tulathromycin, the main component of Increxxa, is administered to livestock via injection and quickly targets the site of the infection in the lungs for quick action and a prolonged half-life, giving cattle more time to build up a powerful defense - February 2021.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Bimeda, Inc, Elanco Animal Health Inc., Merck & Co., Inc., Virbac Corp., etc.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Veterinary Anti-Infectives Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The publisher analyses the Global Veterinary Anti-Infectives Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Veterinary Anti-Infectives Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
• Excel data sheet for the market size will also be provided with the report.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors.
• The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
• Market segmentation
• Competitive Analysis: Comparative analysis of competitor
• Historical, current, and projected size of the market based on value and volume
• Market size of the US states
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market